Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37272535

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jul 13
First author
Tsuboi M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Aug;20(8):504. doi: 10.1038/s41571-023-00791-w.
    note
    Source null
    related pmid
    37311902
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Oct 5;389(14):1341-1342. doi: 10.1056/NEJMc2309385.
    note
    Source null
    related pmid
    37792622
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Oct 5;389(14):1342. doi: 10.1056/NEJMc2309385.
    note
    Source null
    related pmid
    37792623
    relationship
    Comment in

Authors and identifiers

  1. name
    Tsuboi M
    type
    Author
  2. name
    Herbst RS
    type
    Author
  3. name
    John T
    type
    Author
  4. name
    Kato T
    type
    Author
  5. name
    Majem M
    type
    Author
  6. name
    Grohé C
    type
    Author
  7. name
    Wang J
    type
    Author
  8. name
    Goldman JW
    type
    Author
  9. name
    Lu S
    type
    Author
  10. name
    Su WC
    type
    Author
  11. name
    de Marinis F
    type
    Author
  12. name
    Shepherd FA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tsuboi M
    type
    Author
  2. name
    Herbst RS
    type
    Author
  3. name
    John T
    type
    Author
  4. name
    Kato T
    type
    Author
  5. name
    Majem M
    type
    Author
  6. name
    Grohé C
    type
    Author
  7. name
    Wang J
    type
    Author
  8. name
    Goldman JW
    type
    Author
  9. name
    Lu S
    type
    Author
  10. name
    Su WC
    type
    Author
  11. name
    de Marinis F
    type
    Author
  12. name
    Shepherd FA
    type
    Author
bibliography ids
  1. nci-bib-5c5a0677a9f944e8d630571f
book metadata
content sha256
db2b7083265cba8dc1e39d8d9e5b5552dd9c3c89e0fcc3c9871ddcad2865dcd5
document type
citation
dois
  1. 10.1056/NEJMoa2304594
electronic publication date
display
2023 Jun 4
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37272535
immutable id
pubmed:37272535@db2b7083265cba8dc1e39d8d9e5b5552dd9c3c89e0fcc3c9871ddcad2865dcd5
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
2
name
The New England journal of medicine
nlm unique id
0255562
pages
137-147
volume
389
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Aug;20(8):504. doi: 10.1038/s41571-023-00791-w.
    note
    Source null
    related pmid
    37311902
    relationship
    Comment in
  2. citation
    N Engl J Med. 2023 Oct 5;389(14):1341-1342. doi: 10.1056/NEJMc2309385.
    note
    Source null
    related pmid
    37792622
    relationship
    Comment in
  3. citation
    N Engl J Med. 2023 Oct 5;389(14):1342. doi: 10.1056/NEJMc2309385.
    note
    Source null
    related pmid
    37792623
    relationship
    Comment in
outcomes validated
false
pmid
37272535
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
24139c042dca227c57755b0bc9df898b30bc576503ca1890f7ed80c69cbd292f
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Jul 13
precision
day
year
2023
publication types
  1. Randomized Controlled Trial
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37272535/
title
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

Preserved source evidence · Not medical advice